Aptevo Therapeutics Inc. (APVO)
NASDAQ · Healthcare
Aptevo Therapeutics Inc. Net Income 2015–2022
Aptevo Therapeutics Inc. annual/quarterly net income history and growth rate from 2015 to 2022. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Aptevo Therapeutics Inc. net income for the quarter ending March 31, 2022 was -7.7 M, a 6.08% increase year-over-year.
- Aptevo Therapeutics Inc. net income for the twelve months ending March 31, 2022 was -29.9 M, a 11.72% decrease year-over-year.
- Aptevo Therapeutics Inc. annual net income for 2022 was 8.0 M, a 128.21% decrease from 2021.
- Aptevo Therapeutics Inc. annual net income for 2021 was -28.5 M, a 60.32% increase from 2020.
- Aptevo Therapeutics Inc. annual net income for 2020 was -17.8 M, a 56.12% decrease from 2019.
- Aptevo Therapeutics Inc. annual net income for 2019 was -40.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aptevo Therapeutics Inc. Net Income — FAQ
Aptevo Therapeutics Inc. (APVO) net income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Aptevo Therapeutics Inc.'s net income?
Aptevo Therapeutics Inc. (APVO) reported net income of $8M for fiscal 2022.
Where can I see APVO's net income history?
The chart and table above show Aptevo Therapeutics Inc.'s net income by year and by quarter, including the growth rate.